Screener
GNOM vs IDNA
Global X Genomics & Biotechnology ETF vs iShares Genomics Immunology and Healthcare ETF
Key differences
- IDNA is significantly larger than GNOM — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, IDNA has delivered higher annualized returns.
Side-by-side comparison
| GNOM | IDNA | |
|---|---|---|
| Annual cost (TER) | 0.50% | 0.47% |
| Fund size (AUM) | $51M | $160M |
| Since | 2019 | 2019 |
| Dividend yield | 1.38% | 1.05% |
| Asset class | equity | equity |
| Region | north america | — |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +53.6% | +49.2% |
| CAGR 3Y | -2.6% | +8.0% |
| CAGR 5Y | -10.5% | -7.5% |
| Sharpe 3Y | -0.06 | 0.29 |
| Volatility 1Y | 26.15% | 24.43% |
| Max drawdown | -75.00% | -68.26% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to GNOM and IDNA
Explore further